Abattis Bioceuticals Corp

Trending Articles

  1. Isospec launches analysis technology to identify unknown molecules The novel technology can facilitate the detection of trace amounts of unidentified molecules in nutraceutical formulations
  2. Kyowa Hakko’s IMMUSE powers Sensilab’s new IMMUNOFAR Biotic for enhanced immune support The incorporation of IMMUSE facilitates the strengthening of pDC functionality, promoting a healthy immune system
  3. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
  4. Glanbia acquires Flavor Producers for $300m The acquisition adds significantly to Glanbia's Better Nutrition platform, introducing novel flavour offerings
  5. The role of traceability in the nutraceutical supply chain The exponential growth of the nutraceutical sector, combined with the unprecedented growth in online marketplaces, makes nutraceuticals highly vulnerable to vast counterfeiting...

Upcoming event

Vitafoods Europe

14–16 May 2024 | Exhibition | Palexpo, Geneva See all

Related Content

Finance

Abattis acquires Pro Natura BV

Entering into a share purchase agreement through a subsidiary, the acquisition signifies a focus on revenue and profit
Ingredients

Abattis Bioceuticals acquires cannabis producer Gabriola Green Farms

The Canadian biotech company is expanding further into the cannabis market with the agreement, which will see it develop legal cannabis extracts for cosmetics and other products
Subscribe now